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Copy-numbervariations(CNVs)maycontributetogeneticvariationinhumans.Reportsregardingexistenceandcharacteristicsof
CNVsinalargeapparentlyhealthyJapanesecohortarequitelimited.Wereportthedatafromascreeningof213unrelatedJapanese
individuals using comparative genomic hybridization based on a bacterial artiﬁcial chromosome microarray (BAC aCGH). In a
previous paper, we summarized the data by focusing on highly polymorphic CNVs (in ≥5.0 % of the individuals). However, rare
variations have recently received attention from scientists who espouse a hypothesis called “common disease and rare variants.”
Here,wereportCNVsidentiﬁed infewer than10individuals inourstudypopulation. Wefoundatotalof126CNVsat52diﬀerent
BAC regions in the genome. The CNVs observed at 27 of the 52 BAC-regions were found in only one unrelated individual. The
majority of CNVs found in this study were not identiﬁed in the Japanese who were examined in the other studies. Family studies
were conducted, and the results demonstrated that the CNVs were inherited from one parent in the families.
1.Introduction
Genomes vary from one another in multifarious ways, and
thetotalityofthisgeneticvariationunderpinstheheritability
of human traits. Various recent studies show the landscape
of genetic variation and allow estimation of the relative con-
tributions of sequence (base substitutions) and structural
variation (indels, insertions, or deletions; copy-number var-
iations[CNVs],andinversions).AmongDNAsequencevari-
ations in the human genome, CNVs directly contribute to
geneexpression changesthrough genedosage eﬀects;thedis-
tribution of CNVs is now considered to be wider than pre-
viously thought [1–6]. Genome resequencing studies have
shown that CNVs, involving the gain or loss of several hun-
dreds of bases to several hundred kilobases (kb) of the gen-
ome, can be an important source of genetic variation among
human populations of diﬀerent ethnic groups as well as
among individuals. Following the development of method-
ologies and the introduction of new research platforms [7–
12], information regarding the nature and pattern of CNVs
from representative populations has been accumulated. The
functionalimpactofCNVshasbeendemonstratedacrossthe
full range of biology [13], from cellular phenotypes, such as
gene expression [14], to all classes of human disease with an
underlying genetic basis: sporadic, Mendelian, complex, and
infectious (reviewed in [15]).
Clinical geneticists need to discriminate pathogenic from
benign CNVs in their patients and have made extensive use
of data from CNV surveys of apparently healthy individuals
[16]. The mere presence or absence of a variant in such con-
trol data sets is only partially informative, as determination
of the pathogenicity of inherited CNVs is at present limited
by a lack of information on CNV frequency and combina-
tions in apparently healthy individuals. Based on these con-
siderations, examinations of a relatively large number of
individuals from various speciﬁc ethnic groups have recently
been conducted using diﬀerent array platforms, such as BAC
arrays [6, 17, 18], oligo arrays [19–21], and others [22]. The
results are not always consistent, and it is likely that diﬀerent
human populations bear diﬀerent inherited CNVs. The2 Journal of Biomedicine and Biotechnology
numbers of Japanese individuals examined to date are smal-
ler than those in studies of other ethnicities [4]. Polymorphic
CNVs have received considerable attention since they might
play an important role in the etiology of common diseases.
Therefore, more data regarding CNVs should be accumu-
lated from Japanese populations. We summarized the avai-
lable data by focusing on highly polymorphic CNVs (in
≥5.0%oftheindividuals) inapreviouspaper[23].However,
rare variations have recently received attention from scien-
tists who espouse a hypothesis called “common disease and
rare variants,” in contrast to the “common disease-common
variants”hypothesisthatunderpinsmostgenome-wideasso-
ciation studies. In this paper, we focus on CNVs observed at
relatively low frequency (<5.0% of the individuals) in a pop-
ulation residing in Hiroshima and Nagasaki, Japan, using
CGH with BAC clones as targets.
2.Materials
Thestudywasconductedintwostages:Stage(1)80unrelated
Japanese individuals were examined by BAC-aCGH with an
array having 2,241 BAC clones; Stage (2) 133 unrelated Japa-
nese individuals were examined by BAC-aCGH containing
2,622 BAC clones.
2.1. Target BAC Clones. The majority of the clones used in
Stage 1 of this study were selected from the set of cytoge-
neticallymappedP1artiﬁcialchromosome(PAC)clonesand
bacterialartiﬁcialchromosome(BAC)clonesreportedbythe
BACResourceConsortium[26]andobtainedfromeitherthe
Children’s Hospital Oakland Research Institute (Oakland,
CA, USA) or from Invitrogen Inc., Co. (Carlsbad, CA, USA).
InStage2,togetherwiththeBACclonesinStage1,additional
381 BAC clones were used, a majority of which were colla-
boratively obtained from Dr. Matsumoto of Yokohama City
University.Atotalof2,241clonesofchromosomalfragments
from chromosome 1 to chromosome 22 were used in Stage 1
and2,622clonesinStage2.Theclonesweredistributedevery
1.2 Mb across all human autosomes in Stage 1 and every 1.1
Mb in Stage 2. In addition to autosomal clones, four kinds
of X-chromosomal clones were used as internal references.
With respect to the examinations in Stage 1, three sets of
arrays were constructed as described in the previous paper
[27]. For Stage 2, all of the clones were printed onto one glass
slide.
2.2. Genomic DNA Samples. The genomic DNA samples
used in this study were reported in a previous study [23,
27]. In brief, the DNA used for the population studies and
the family studies was extracted from lymphoblastoid cell
lines obtained from the oﬀspring of atomic-bomb survivors
and their family members. Lymphoblastoid cell lines were
derivedfromacryopreservedarchiveoffamiliesconsistingof
father, mother, and oﬀspring from Hiroshima and Nagasaki
for whom permanent cell lines have been established by
Epstein-Barr (EB) virus transformation. The genomic DNA
was isolated using conventional methods as described in
detail elsewhere [28]. A total of 305 of the oﬀsprings were
screened initially. Since the oﬀspring in some cases included
siblings, we selected one representative oﬀspring to create a
group of “unrelated individuals,” thereby avoiding any dup-
lication of CNVs from families containing two or more sibl-
ings, in accordance with the rules described in a previous
report [23]. In this study, 80 individuals (40 from each city)
were included in examinations in Stage 1 and 133 (84 from
Hiroshima, 49 from Nagasaki) in Stage 2. The individuals
provided their informed consent prior to the study. The Ins-
titutional Review Board of our foundation approved this
study.
3. Methods
3.1. Array Preparation. The arrays were prepared as descri-
bed in the previous paper [23]. In brief, with respect to
Stage 1, cloned DNA was digested by NotI. On the other
hand, in Stage 2, cloned DNA was digested with MseI, and
the fragmented DNAs were ampliﬁed by ligation-mediated
PCR carried out as described by Snijders et al. [29]. In both
stages, the target DNAs (0.5μg/μL) were dissolved in 50%
dimethylsuloxide and printed in triplicate onto the glass
slides (Matsunami Glass Co. Ltd.) using the Aﬀymetrix 417
Arrayer (Aﬀymetrix).
3.2. Screening by the Array CGH Method. The screenings
of both stages were conducted following the procedures
describedpreviously[23].Inbrief,forlabelingDNA,testand
reference genomic DNA (1.25μge a c h )w a sc u tb yBamHI
and labeled by a random-priming method with Cyanine-
5- and Cyanine-3-labeled dUTP (Cy5- and Cy3-dUTP;
PerkinElmer Life Sciences, Wellesley, MA, USA). Human
CotI DNA was employed to block repetitive sequences of the
labeled probes.
Prehybridization was conducted to block repetitive seq-
uence binding of target DNA on the arrays and to prevent
nonspeciﬁc binding of probe DNA to the targets. Following
the initial incubation, the prehybridization solution was re-
moved, and hybridization solution with Cy-labeled DNA
(prepared as described above) was added. The prehybridiza-
tion and the hybridization were conducted with continuous
mixing overnight at 37◦C. After hybridization, the arrays
were washed by the procedures reported previously [27]. All
oftheprocedureswereconductedusingtheGeneTACHybri-
dization Station (Genomic Solutions Inc., Ann Arbor, MI,
USA).
After washing procedures, ﬂuorescent images of the hyb-
ridizedarrayswereobtainedusingaScanArray5000confocal
laser scanner (PerkinElmer Life Sciences). ArraySuite (Scan-
alytics Inc., Fairfax, VA, USA) in Stage 1 and Gene Pix (Axon
Instruments,Sunnyvale,CA)inStage2wereusedtoquantify
the ﬂuorescence of each spot on the array images. We then
processed the data using software speciﬁcally developed to
identify “CNVs” [27].
3.3. Procedures of Population Studies. The population studies
were conducted in accordance with accepted procedures as
described in the previous paper [27]. In brief, hybridization
was performed as follows: mixtures of (a) Cy5-labeled refer-
ence DNA and Cy3-test DNA, and (b) inverse labeling withJournal of Biomedicine and Biotechnology 3
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Figure 1: Characterization of a loss-type CNV detected on a BAC-clone RP11-81H5. A genome map of the RP11-81H5-containing region
wasobtainedfromtheUCSCGenomeBrowserwebsite.Thedistance(bp)fromthep-terminalofchromosome15isshownintheuppermost
part.ThepositionsofPCRprimersexaminedareshownbysolidboxes.Theexperimentalconditionsaredescribedmorepreciselyinthetext.
The relative copy number of each site was normalized using the quantity of the ampliﬁed segment of a portion of a diﬀerent chromosome
(Chromosome 16) as a standard (relative copy number = 2) and was shown as mean ± SD (n = 3).
Cy3-reference DNA and Cy5-test DNA were applied to the
slides. The two complementary hybridizations (i.e., (a) and
(b)) were conducted for each individual. The variations in
a given sample from a single individual that were identiﬁed
consistently in both complementary hybridizations ((a) and
(b)) were regarded as putative CNVs. Since only DNA seg-
ments detected as putative CNVs in two individuals or more
were regarded as true CNVs, further analyses were not con-
ducted. On the contrary, when CNVs were detected in only
one individual, all were conﬁrmed with repeated examina-
tions using arrays.
3.4. The qPCR Procedure for CNVs Identiﬁed in Oﬀspring.
The qPCR procedure was performed using SYBR premix EX
Taq (Takara-Bio, Ohtsu, Japan) and the Light Cycler Sys-
tem (Roche Diagnostics Japan, Tokyo, Japan), according to
the procedures described in the previous paper [27]. The
results were analyzed with Light Cycler Data Analysis soft-
ware using a second derivative maximum model. Relative
DNA content of variants for every amplimer was calculated
using a “normal” individual without CNVs as controls. The
relativecopynumberofeachsitewasnormalizedusingquan-
tity of the ampliﬁed segment of a portion of a diﬀerent chro-
mosome (chromosome 16:78888541–78888690; this posi-
tion empirically showed the smallest deviation among many
samples in our experiments) as a standard (relative copy
number = 2) and was indicated as mean ± SD (n = 3).
3.5. Procedure of Family Studies for Conﬁrmation of Inheri-
tance of CNVs Identiﬁed Once in This Study. For the CNVs
identiﬁed in only one oﬀspring, further examinations were
carried out for conﬁrmation of inheritance. The family stud-
ies using qPCR for the CNVs were conducted using DNAs
from the mother, the father and sibling of oﬀspring, if avai-
lable. The procedures of qPCR were the same as above.
4. Results
4.1. Population Studies. We examined 213 unrelated indivi-
duals. The main purpose of this paper is to report the data
accumulated about CNVs found in <5.0% of the individuals.
(The number of CNVs was less than 10 in each BAC region.)
The results obtained from the population studies are shown
in Tables 1 and 2.I nTable 1, the CNVs identiﬁed in two
individuals or more are summarized. On the other hand, in
Table 2, the CNVs identiﬁed in only one individual through
this study are summarized. A total of 126 CNVs were
identiﬁed at 52 diﬀerent BAC regions in the genome. The
CNVs observed at 27 of 52 BAC regions were found in only
one unrelated individual, and all of them were conﬁrmed
by repetitive analysis using the same array system as in the
population studies. The family studies by qPCR were con-
ducted for 23 of 27 CNVs, and the results revealed that those
23 CNVs were inherited from one of the parents. The inheri-
tance of CNVs from the remaining two oﬀsprings was not4 Journal of Biomedicine and Biotechnology
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Figure 2:Characterizationofaloss-typeCNVdetectedonaBAC-cloneRP11-90M13.AgenomemapoftheRP11-90M13-containingregion
was obtained from the UCSC Genome Browser website. The distance (bp) from the p-terminal of chromosome 8 is shown in the uppermost
part. That region contains two genes, protein phosphatase 2, regulatory subunit B, alpha (PPP2R2A) and early B-cell factor 2 (EBF2). The
positions of PCR primers examined are shown by solid boxes. The individual has variant fragments with a deletion that contains a part of
the 7th intron of the PPP2R2A gene and the promoter region of the EBF2 gene.
conﬁrmed, since DNA from the parents was not obtained.
On the other hand, the CNVs on two BAC clones (RP11-
88B18, RP11-86B6) were identiﬁed in only one unrelated
individual. In fact, however, they were observed in indi-
viduals who were not selected as “unrelated” individuals.
The numbers of individuals who expressed the CNVs are
described in the parentheses in Table 2. For that reason, we
did not conduct family studies for those CNVs.
4.2. The Typical Patterns of Three Family Studies of CNVs
on BAC Clones by qPCR Analysis. As typical examples of
family studies, the results of qPCR carried out for the
CNVs observed in three BAC-clone regions are described
in Figure 1 (RP11-81H5), Figure 2 (RP11-90M13), and
Figure 3 (RP11-90O18 and RP11-90C3). For the ﬁrst case,
a single 180,264bps deletion was observed in an oﬀspring.
The family study demonstrated that the CNV was inherited
from the mother. There is no gene in this BAC clone region.
For the second case, the BAC-clone (RP11-90M13) contains
twogenes,proteinphosphatase2,regulatorysubunitB,alpha
(PPP2R2A) and early B-cell factor 2 (EBF2). The deletion-
type CNV was conﬁrmed by qPCR, and the CNV was found
to be inherited from the father. The deletion covered part of
intron 7 of PPP2R2A and the promoter region of EBF2.F o r
the last case, as shown in Figure 3, the CNV was covered by
two BAC clones (RP11-90O18 and RP11-90C3). This result
was revealed by qPCR, and the CNV was found to be inhe-
rited from the father. The CNV contained the series of zinc
ﬁnger protein families (ZNF 107, 138, 273, 117, 92).
4.3. Comparing Our Data with Published Data. Many seg-
mental duplications have already been summarized in pub-
lic databases, such as the Database of Genomic Variants
(DGV Database; http://projects.tcag.ca/variation/), UCSC
Human Genome Browser (UCSC Database. http://genome
.ucsc.edu/index.html), and NCBI Map Viewer (NCBI Data-
base; http://www.ncbi.nlm.nih.gov/mapview/mapsearch.cgi).
The known CNVs have also been reported in the same data-
bases. However, when the CNVs reported in the databases
or papers were too small to be detected by our BAC-aCGH
methods, we assumed that they were diﬀerent from our
CNVs. The CNV data obtained in our studies, including an
indication of the presence or absence of CNVs already repor-
ted in other databases, are summarized in Tables 1 and 2.
4.4. Comparing Our Data with the Data of Japanese Published
by Other Groups. Compared to Caucasian populations, very
little information about CNVs in Japanese populations has
beensystematicallyscreened.Wecomparedourdatawiththe
data of Japanese populations from the HapMap project asJournal of Biomedicine and Biotechnology 5
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Figure 3: Characterization of a gain-type CNV detected on a BAC-clone RP11-90O18 and RP11-90C3. A genome map of both RP11-90
O18- and RP11-90C3-containing regions was obtained from the UCSC Genome Browser website. The distance (bp) from the p-terminal of
chromosome 7 is shown in the uppermost part. That region contains zinc ﬁnger print protein gene families, that is, ZNF 107, 138, 273, 117,
and 92. The positions of PCR primers examined are shown by the solid boxes.
reported by Redon et al. [4], in which CNVs were examined
by tiling BAC array. In addition to the data by BAC array,
three groups, including Redon et al. [4], reported the data
of Japanese populations based on examinations conducted
using oligo-array methods, although each group used a dif-
ferent array platform [24, 25]. These results are also summa-
rized in Tables 1 and 2. In the case where a multiple number
of CNVs were identiﬁed in our study (Table 1), the CNVs
in 16 of 25 BAC regions were reported in the other reports.
Moreover, regarding one individual, the CNVs identiﬁed in
nine of 27 BAC regions were reported in the data reported
by the others, although we should emphasize again that the
CNVs identiﬁed in our BAC region are not exactly the same
as those reported by the others. The majority of CNVs iden-
tiﬁed in our study tend not to be identiﬁed in the other re-
ports. Thus, they can be considered novel CNVs in the gen-
eral Japanese population.
4.5. Genes and Disease-Related Genes. We summarized some
of the genes and disease-related genes that overlap with
the BAC-clone region for our CNVs (Table 3). In addition,
mRNAs also have been reported in the databases, but they
are too numerous to describe here. All BAC-clone regions
contained at least one mRNA, although the functions of
a majority of the mRNAs are not yet known (data not
shown).
5. Discussion
We examined 213 unrelated Japanese individuals using BAC-
aCGH and found a total of 126 CNVs on 52 diﬀerent BAC
regions in the genomes. The CNVs observed on 27 of the 52
BAC-regions were found in only one unrelated individual.
The family studies were conducted for 23 CNVs, and the
results demonstrated that these were inherited from one of
the parents. A fraction of the regions involved in the CNVs
observed in our study (i.e., 34 of 126 or about 27%; Tables
1 and 2) were not reported previously in other studies listed
in the database. Thus, they are considered novel CNVs. In
contrast, the data of highly polymorphic CNVs [23]d e m -
onstrated that only 8% (55 of 680) had not been reported.
This result showed that a signiﬁcantly large number of novel
CNVs have been identiﬁed among relatively less frequent
CNVs (χ2 = 36.64, P = 5.10 × 10
−10). This ﬁnding sug-
gests that the structural rearrangements for creating less fre-
quent CNVs are evolutionarily recent. We thus paid atten-
tion to diﬀerences in the number of CNVs identiﬁed in
Hiroshima compared to Nagasaki. With respect to the CNVs6 Journal of Biomedicine and Biotechnology
Table 1: Summary of the CNVs detected in plural unrelated individuals.
Clone
number
Chrom.
number
Position
(Mb)
Variants Known
variant
Segmental
duplication Hiroshima(2) Nagasaki(3) Redon(4) Redon(5) Park
et al.
Ikeda
et al.
Amp(1) Delete [4][ 4][ 24][ 25]
RP11-81B15 1 150.7 9 0 Pre(6) Abs(8) 45 A b s (10) Abs Pre Abs
RP11-91G12 1 194.9 2 0 Pre Pre(9) 20 A b s A b s P r e P r e
RP11-118M12 2 241.2 3 0 Pre Pre 0 3 Pre(11) Pre Abs Abs
RP11-91F17 3 167.5 2 0 Pre Abs 2 0 Abs Abs Abs Abs
RP11-101J14 4 8.1 2 0 Pre Abs 0 2 Abs Abs Abs Abs
RP11-80P12 4 132.3 2 0 Pre Abs 1 1 Abs Abs Abs Abs
RP11-23D23 7 0.84 4 0 Pre Abs 3 1 Abs Abs Abs Abs
RP11-90C3 7 64.3 1 1 Pre Abs 1 1 Pre Abs Pre Pre
RP11-35P20 7 71.6 2 0 Pre Pre 0 2 Pre Pre Pre Abs
RP11-45M12 8 3.9 0 2 Pre Abs 2 0 Pre Pre Pre Abs
RP11-113B7 8 4.2 0 4 Pre Abs 4 0 Pre Pre Abs Abs
RP11-89I12 8 4.4 0 4 Pre Abs 4 0 Pre Pre Pre Abs
RP11-79I19 8 3.7 0 4 Pre Abs 4 0 Pre Pre Abs Abs
RP11-310C13 9 113.5 6 1 Abs(7) Abs 5 2 Abs Abs Abs Abs
RP11-79M9 10 77.7 6 0 Abs Abs 4 2 Abs Abs Abs Abs
RP11-326B4 13 66.8 8 0 Abs Abs 5 3 Abs Abs Abs Abs
RP11-89A14 13 82.4 5 0 Pre Abs 4 1 Abs Abs Abs Abs
RP11-531P20 13 84.4 2 0 Pre Abs 2 0 Abs Pre Abs Abs
RP11-143O10 13 88.5 4 0 Pre Abs 2 2 Abs Abs Pre Abs
RP11-91C17 14 43.2 5 0 Abs Abs 3 2 Abs Abs Abs Abs
RP11-194H7 15 32.5 2 0 Pre Pre 2 0 Pre Abs Abs Abs
RP11-152F13 15 80.9 0 9 Pre Pre 5 4 Pre Abs Abs Abs
RP11-88B2 18 61.8 0 2 Pre Abs 0 2 Pre Abs Pre Abs
RP11-13J15 21 24.1 0 4 Pre Abs 2 2 Abs Abs Abs Pre
CTA-526G4 22 20.6 1 2 Pre Abs 2 1 Pre Abs Abs Pre
Total of CNVs 66 33 63 36
(1)Ampliﬁcation.NumberofCNVsobservedinHiroshimaindividual (2)andinNagasakiindividual (3). (4)Radon’sBACdata. (5)Radon’soligo-arraydata.CNVs
present (6)or absent (7)in previous papers. Segmental duplication absent (8)or present (9)in BAC-clones on which CNVs were observed. CNVs absent (10)or
present (11)in Japanese.
observed multiple times, 12 of 25 were identiﬁed in one city.
TheseCNVs appearto be so-called“private polymorphisms”
occurring more recently than the others. On the other hand,
quite a small number (21 of 126; about 17%) of the CNVs in
this report were found on the BAC clones that overlapped
with segmental duplication (Tables 1 and 2). A majority
(about 63%) of highly polymorphic CNVs, however, were
observedontheBAC-cloneoverlappingwithsegmentaldup-
lication (see Table 1 in [23]). This result suggests that seg-
mental duplication might play a signiﬁcant role in the cre-
ation of highly polymorphic CNVs. These observations are
supported by previous data from Sharp et al. [17], who re-
ported the sharing of CNVs among several populations,
meaning that the speciﬁc genomic imbalances either pre-
dated the migration of modern humans from Africa or arose
independently in diﬀerent populations.
On the other hand, the data representing Japanese pop-
ulations are based on reports from three groups. We com-
pared our CNV data to that of these other reports [4, 24, 25].
The CNVs found in 27 of 52 BAC regions (about 52%) were
not identiﬁed by the other groups. Speculation as to the
reason for this includes the possibility that since the CNVs
were private polymorphisms as mentioned above, they were
not identiﬁed in the Japanese populations used in the other
works.
In humans, it is estimated that around 23% of currently
knownCNVsresideinknownorputativegenes.ManyCNVs
that lie outside genic regions of the genome may still have
a signiﬁcant inﬂuence on gene expression by aﬀecting gene
regulatory elements [30]. Another important area of explo-
ration is linkage disequilibrium (LD), that is, nonrandom
association between alleles at diﬀerent loci, between CNVs
and other genomic variants (especially SNPs), which may
provide important insight into the genomic evolution (e.g.,
the recombination patterns) of CNVs [31, 32]. However,
studies of LD between CNVs and SNPs are hindered by
the fact that CNVs generally reside in genomic regions
associated with segmental duplications and/or repeat-rich
regions, which are diﬃcult to sequence and use for detection
of SNPs.Journal of Biomedicine and Biotechnology 7
Table 2: Summary of the CNVs detected in single unrelated individuals.
Clone
number
Chrom.
number
Position
(Mb)
Delete
or Amp(1)
Known
variant
Segmetal
duplication
Known
inheritance(2)
Redon
[4]
Redon(3)
[4]
Park et al.
[24]
Ikeda et al.
[25]
RP5-895L2 1 231.9 Deletion Abs(4) Abs(6) MO Abs(8) Abs Abs Abs
RP11-204C23 3 3 Delete Pre(5) Abs FA Abs Abs Abs Abs
RP11-80D22 4 43.7 Amp Pre Abs FA Abs Abs Abs Abs
RP11-22O8 4 141.1 Deletion Abs Abs ND Abs Abs Abs Abs
RP11-104N13 6 165 Deletion Pre Abs FA Abs Abs Abs Abs
RP11-90O18 7 63.8 Amp Pre Abs FA Abs Abs Abs Abs
RP11-79I19 8 4 Delete Pre Abs MO Abs Pre Abs Abs
RP11-90J21 8 8.8 Amp Pre Abs FA Abs Abs Abs Abs
RP11-90M13 8 25.9 Deletion Abs Abs FA Abs Abs Abs Abs
RP11-91G3 8 91.1 Deletion Pre Abs ND Pre(9) Pre Abs Abs
RP11-91H19 10 58.2 Deletion Pre Abs FA Abs Abs Abs Abs
RP11-176H12 10 65.7 Amp Pre Abs MO Abs Abs Abs Abs
RP11-18B9 11 40.3 Delete Pre Abs MO Abs Abs Abs Abs
RP11-75H24 11 58.6 Amp Pre Pre(7) MO Pre Abs Pre Abs
RP11-90N7 12 11.4 Amp Pre Pre MO Abs Abs Pre Abs
RP11-86C3 13 89 Deletion Pre Abs FA Abs Abs Abs Abs
RP11-80H14 15 20.5 Amp Pre Abs FA Abs Abs Abs Pre
RP11-81H5 15 44.7 Delete Abs Abs MO Abs Abs Pre Abs
RP11-90E5 15 98.4 Amp Pre Abs FA Abs Abs Abs Abs
RP11-79I15 16 16.6 Deletion Pre Pre MO Pre Pre Abs Abs
RP11-89L6 16 75.7 Amp Abs Abs MO Abs Abs Abs Abs
CTB-15E16 16 79.0 Amp Pre Abs MO Abs Abs Abs Abs
RP11-265I6 18 36.1 Delete Abs Abs FA Abs Abs Abs Abs
RP11-89N1 18 76.0 Amp Pre Abs MO Abs Abs Abs Pre
RP5-908M14 20 60.4 Amp Pre Abs MO Pre Abs Pre Abs
Remarks Each CNV as below was detected in three individuals in diﬀerent families, but two of them were detected in individuals
who were not selected as an unrelated individual. Both CNVs were not identiﬁed in three other studies of Japanese
RP11-88B18 10 56.6 Deletion Pre Abs ND 1 (3)
RP11-86B6 13 104 Amp Abs Abs ND 1 (3)
(1)Ampliﬁcation. (2)CNVs were inherited from the mother (MO) or the father (FA). (3)Data from Aﬀymetrix oligo array. CNVs absent (4)or present (5)in
previous papers. Segmental duplication absent (6)or present (7)in BAC clones on which CNVs were observed. CNVs absent (8)or present (9)in Japanese data
from three types of oligo arrays.
Recent association studies have attempted to link CNVs
with expression proﬁles, diseases, and known phenotypic
diﬀerences. On the other hand, distribution of CNVs diﬀers
depending on genetic background, and population-speciﬁc
CNVs might account for the divergence of some physiolog-
ical traits and disease prevalence among populations [31].
Like SNPs, CNVs also show variability among populations;
therefore, comprehensive CNV information is needed when
applying CNVs as genetic markers in disease or trait studies.
Forthereasonscitedabove,wemadeplanstoaccumulate
Japanese data in which we provide information about the
relation between Japanese CNV data and phenotypic dif-
ferences correlated with reported diseases. In our previous
paper [23], we summarized such data by focusing on highly
polymorphic CNVs found in ≥5.0% of the individuals.
More recent studies based on advanced molecular tech-
nologies, such as genome-wide association studies [33, 34]
and next generation sequencing [35, 36], reported that many
genes appear to play important roles in the etiology of com-
mon diseases. Depending on newly developed technologies,
rare variations have recently received attention from scien-
tists who espouse a hypothesis called “common disease and
rare variants.” In this paper, we summarized CNVs that
were identiﬁed in fewer than 10 individuals in our previous
population study. We focused on genes reported in the
DGV, UCSC, and NCBI databases (Table 3), although many
mRNAs were also listed in them. Since these genes are good
candidate markers for enabling us to examine the etiology of
common diseases and phenotypical heterogeneities among
individuals, our CNVs have the potential to become useful
markers in future studies.
6. Conclusion
In this study, 34 CNVs were new, indicating that CNV cover-
age of the human genome is still incomplete and that there is8 Journal of Biomedicine and Biotechnology
Table 3: Genes in BAC clones with CNVs.
BAC-clone number Chrom. number Position (Mb) Genes
RP11-81B15 1 150.7 Late corniﬁed envelope 5A (LCE5A), 3A(LCE3A), 3B(LCE3B), 3C(LCE3C),
3D(LCE3D), 3E(LCE3E), cysteine-rich C-terminal 1 (CRCT1)
RP11-91G12 1 194.9 Complement factor H (CFH). Complement factor H-related 3 (CFHR3)
RP11-118M12 2 241.2 Aquaporin 12B (AQP12B), aquaporin 12A (AQP12A), kinesin family
member 1A (KIF1A)
RP11-101J14 4 8.1 Actin binding LIM protein family, member 2 (ABLIM2)
RP11-23D23 7 0.84 ArfGAP with dual PH domains 1 (ADAP1)
RP11-90C3 7 64.3 Integrator complex subunit 4-like 1 (INTS4L1)
RP11-35P20 7 71.6 tRNA-yW synthesizing protein 1 homolog B (S.cerevisiae) (TYW1B)
RP11-45M12 8 3.9 CUB and Sushi multiple domains 1 (CSMD1)
RP11-113B7 8 4.2 CUB and Sushi multiple domains 1 (CSMD1)
RP11-89I12 8 4.4 CUB and Sushi multiple domains 1 (CSMD1)
RP11-79I19 8 3.7 CUB and Sushi multiple domains 1 (CSMD1)
RP11-310C13 9 113.5 Chromosome 9 open reading frame 84 (C9orf84)
RP11-79M9 10 77.7 Chromosome 10 open reading frame 11 (C10orf11)
RP11-326B4 13 66.8 Protocadherin 9 (PCDH9)
RP11-91C17 14 43.2 Rho GTPase activating protein 5 (ARHGAP5)
RP11-194H7 15 32.5 Golgin A8 family, member A (GOLGA8A)
RP11-152F13 15 80.9
Ubiquitin-conjugating enzyme E2Q family member 2 pseudogene 2
(UBE2Q2P2), golgin A6 family-like 9 (GOLGA6L9), cytoplasmic
polyadenylation element binding protein 1, golgin A2 pseudogene
(LOC727849), cytoplasmic polyadenylation element binding protein
1(CPEB1)
CTA-526G4 22 20.6 Topoisomerase (DNA) III beta (TOP3B)
RP11-90O18 7 63.8 Zinc ﬁnger protein 107 (ZNF107),zinc ﬁnger protein 138 (ZNF138)
RP11-79I19 8 4 CUB and Sushi multiple domains 1 (CSMD1)
RP11-90J21 8 8.8 Exoribonuclease 1 (ERI1)
RP11-90M13 8 25.9 Early B-cell factor 2 (EBF2)
RP11-91G3 8 91.1 Calbindin 1, 28kDa (CALB1)
RP11-90N7 12 11.4 Proline-rich protein BstNI subfamily 4 (PRB4), proline-rich protein BstNI
subfamily 1 (PRB1), proline-rich protein BstNI subfamily 2 (PRB2)
RP11-80H14 15 20.5 Tubulin, gamma complex-associated protein 5 (TUBGCP5), cytoplasmic
FMR1 interacting protein 1 (CYFIP1)
RP11-81H5 15 44.7 MicroRNA 548a-3 (MIR548A3)
RP11-90E5 15 98.4 ADAM metallopeptidase with thrombospondin type 1 motif, 17
(ADAMTS17)
RP11-89N1 18 76.0
Ribosome binding factor A (putative) (RBFA), ADNP homeobox 2 (ADNP2),
hypothetical LOC100130522 (LOC100130522), par-6 partitioning defective 6
homolog gamma (C. elegans)( P A R D 6 G )
RP5-908M14 20 60.4 Ribosomal protein S21 (RPS21), Cdk5 and Abl enzyme substrate 2
(CABLES2), chromosome 20 open reading frame 151 (C20orf151)
diversity between the Japanese and other ethnic populations.
Moreover, the CNVs found in about two-thirds of the BAC
regions examined in our study were not identiﬁed in the
studies in which three groups examine Japanese populations
using diﬀerent array platforms. The newly identiﬁed CNVs
extend the coverage of CNVs in the human genome (also the
general Japanese population). Some CNVs contained genes
that might be related to phenotypic heterogeneity among
individuals. Moreover, it is expected that the CNVs could
now be taken into consideration when genetic studies, for
example, CNV association studies, are conducted.
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